SI0956034T1 - Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin - Google Patents
Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycinInfo
- Publication number
- SI0956034T1 SI0956034T1 SI9730389T SI9730389T SI0956034T1 SI 0956034 T1 SI0956034 T1 SI 0956034T1 SI 9730389 T SI9730389 T SI 9730389T SI 9730389 T SI9730389 T SI 9730389T SI 0956034 T1 SI0956034 T1 SI 0956034T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cyclosporin
- rapamycin
- autoimmune
- hydroxyethyl
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9615942.1A GB9615942D0 (en) | 1996-07-30 | 1996-07-30 | Organic compounds |
GBGB9705684.0A GB9705684D0 (en) | 1997-03-18 | 1997-03-18 | Organic compounds |
EP97937526A EP0956034B1 (en) | 1996-07-30 | 1997-07-29 | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin |
PCT/EP1997/004123 WO1998004279A1 (en) | 1996-07-30 | 1997-07-29 | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
Publications (1)
Publication Number | Publication Date |
---|---|
SI0956034T1 true SI0956034T1 (en) | 2002-12-31 |
Family
ID=27238941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9730389T SI0956034T1 (en) | 1996-07-30 | 1997-07-29 | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin |
Country Status (1)
Country | Link |
---|---|
SI (1) | SI0956034T1 (en) |
-
1997
- 1997-07-29 SI SI9730389T patent/SI0956034T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ333657A (en) | A pharmaceutical composition comprising cyclosporin A and 40-O-(2-hydroxyethyl)-rapamycin | |
AU5219198A (en) | Method to prevent transplant rejection | |
HK1010853A1 (en) | Stent and the fabrication method thereof | |
IL107190A (en) | Immunosuppressive pharmaceutical compositions comprising rapamycin carbamates and certain such novel compounds | |
AU3121797A (en) | Intraluminal stent | |
AU5355598A (en) | Variable flexibility stent | |
WO1998002441A3 (en) | Non immunosuppressive antifungal rapalogs | |
HUP9902922A3 (en) | Plant immunization compositions | |
ZA978725B (en) | Herbicidal and plant growth regulant compositions and the use thereof | |
HUP9701038A3 (en) | Equipment for storing and total emptyng fats | |
IL135935A0 (en) | Shaped polyurethane bodies for use as implants | |
EP0876157A4 (en) | Methods and compositions for passive immunotherapy | |
DE59711381D1 (en) | Stent | |
ZA976110B (en) | Elastomers processes for their manufacture and articles made from these elastomers | |
SI0956034T1 (en) | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin | |
HUP9801123A3 (en) | Method to prevent transplant rejection | |
IL121931A (en) | Pharmaceutical compositions for preventing allograft rejection | |
GB9619633D0 (en) | Recombinant plant cells | |
DE59710344D1 (en) | Stent | |
AU4371296A (en) | Compositions and methods for preventing and treating allograft rejection | |
EP0882815A4 (en) | Electrochemical plant | |
GB9622977D0 (en) | Plant support | |
AU128266S (en) | Shark protective cage | |
GB9616082D0 (en) | Prosthetic support | |
SI0917460T1 (en) | Cyclosporin formulation |